Hepatitis C Virus Nucleotide Inhibitors PSI-352938 and PSI-353661 Exhibit a Novel Mechanism of Resistance Requiring Multiple Mutations within Replicon RNA

被引:41
作者
Lam, Angela M. [1 ]
Espiritu, Christine [1 ]
Bansal, Shalini [1 ]
Steuer, Holly M. Micolochick [1 ]
Zennou, Veronique [1 ]
Otto, Michael J. [1 ]
Furman, Phillip A. [1 ]
机构
[1] Pharmasset Inc, Princeton, NJ 08540 USA
关键词
IN-VITRO; EFFICIENT REPLICATION; SUBGENOMIC REPLICON; CROSS-RESISTANCE; CELL-CULTURE; POLYMERASE; RIBAVIRIN; HCV; NS3; COMBINATION;
D O I
10.1128/JVI.05639-11
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
PSI-352938, a cyclic phosphate nucleotide, and PSI-353661, a phosphoramidate nucleotide, are prodrugs of beta-D-2'-deoxy-2'-alpha-fluoro-2'-beta-C-methylguanosine-5'-monophosphate. Both compounds are metabolized to the same active 5'-triphosphate, PSI-352666, which serves as an alternative substrate inhibitor of the NS5B RNA-dependent RNA polymerase during HCV replication. PSI-352938 and PSI-353661 retained full activity against replicons containing the S282T substitution, which confers resistance to certain 2'-substituted nucleoside/nucleotide analogs. PSI-352666 was also similarly active against both wild-type and S282T NS5B polymerases. In order to identify mutations that confer resistance to these compounds, in vitro selection studies were performed using HCV replicon cells. While no resistant genotype 1a or 1b replicons could be selected, cells containing genotype 2a JFH-1 replicons cultured in the presence of PSI-352938 or PSI-353661 developed resistance to both compounds. Sequencing of the NS5B region identified a number of amino acid changes, including S15G, R222Q, C223Y/H, L320I, and V321I. Phenotypic evaluation of these mutations indicated that single amino acid changes were not sufficient to significantly reduce the activity of PSI-352938 and PSI-353661. Instead, a combination of three amino acid changes, S15G/C223H/V321I, was required to confer a high level of resistance. No cross-resistance exists between the 2'-F-2'-C-methylguanosine prodrugs and other classes of HCV inhibitors, including 2'-modified nucleoside/-tide analogs such as PSI-6130, PSI-7977, INX-08189, and IDX-184. Finally, we determined that in genotype 1b replicons, the C223Y/H mutation failed to support replication, and although the A15G/C223H/V321I triple mutation did confer resistance to PSI-352938 and PSI-353661, this mutant replicated at only about 10% efficiency compared to the wild type.
引用
收藏
页码:12334 / 12342
页数:9
相关论文
共 30 条
[21]   Substrate complexes of hepatitis C virus RNA polymerase (HC-J4):: Structural evidence for nucleotide import and De-novo initiation [J].
O'Farrell, D ;
Trowbridge, R ;
Rowlands, D ;
Jäger, J .
JOURNAL OF MOLECULAR BIOLOGY, 2003, 326 (04) :1025-1035
[22]   Resistance to Direct Antiviral Agents in Patients With Hepatitis C Virus Infection [J].
Sarrazin, Christoph ;
Zeuzem, Stefan .
GASTROENTEROLOGY, 2010, 138 (02) :447-462
[23]   A Comprehensive Structure-Function Comparison of Hepatitis C Virus Strain JFH1 and J6 Polymerases Reveals a Key Residue Stimulating Replication in Cell Culture across Genotypes [J].
Schmitt, Melanie ;
Scrima, Nathalie ;
Radujkovic, Danijela ;
Caillet-Saguy, Celia ;
Simister, Philip C. ;
Friebe, Peter ;
Wicht, Oliver ;
Klein, Rahel ;
Bartenschlager, Ralf ;
Lohmann, Volker ;
Bressanelli, Stephane .
JOURNAL OF VIROLOGY, 2011, 85 (06) :2565-2581
[24]  
Schmitz Uli, 2008, Recent Pat Antiinfect Drug Discov, V3, P77, DOI 10.2174/157489108784746597
[25]   Structural and Functional Analysis of Hepatitis C Virus Strain JFH1 Polymerase [J].
Simister, Philip ;
Schmitt, Melanie ;
Geitmann, Matthis ;
Wicht, Oliver ;
Danielson, U. Helena ;
Klein, Rahel ;
Bressanelli, Stephane ;
Lohmann, Volker .
JOURNAL OF VIROLOGY, 2009, 83 (22) :11926-11939
[26]   Discovery of a β-D-2′-Deoxy-2′-α-fluoro-2′-β-C-methyluridine Nucleotide Prodrug (PSI-7977) for the Treatment of Hepatitis C Virus [J].
Sofia, Michael J. ;
Bao, Donghui ;
Chang, Wonsuk ;
Du, Jinfa ;
Nagarathnam, Dhanapalan ;
Rachakonda, Suguna ;
Reddy, P. Ganapati ;
Ross, Bruce S. ;
Wang, Peiyuan ;
Zhang, Hai-Ren ;
Bansal, Shalini ;
Espiritu, Christine ;
Keilman, Meg ;
Lam, Angela M. ;
Steuer, Holly M. Micolochick ;
Niu, Congrong ;
Otto, Michael J. ;
Furman, Phillip A. .
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (19) :7202-7218
[27]   Dynamics of subgenomic hepatitis C virus replicon RNA levels in Huh-7 cells after exposure to nucleoside antimetabolites [J].
Stuyver, LJ ;
McBrayer, TR ;
Tharnish, PM ;
Hassan, AEA ;
Chu, CK ;
Pankiewicz, KW ;
Watanabe, KA ;
Schinazi, RF ;
Otto, MJ .
JOURNAL OF VIROLOGY, 2003, 77 (19) :10689-10694
[28]   Sequence variation of NS3 and NS4A in hepatitis C virus (HCV) replicons following exposure to ITMN-191 concentrations likely to encompass those achieved in human liver following clinical dosing [J].
Thompson, A. J. V. ;
McHutchison, J. G. .
JOURNAL OF VIRAL HEPATITIS, 2009, 16 (06) :377-387
[29]   INX-08189, a Phosphoramidate Prodrug of 6-O-Methyl-2′-C-Methyl Guanosine, Is a Potent Inhibitor of Hepatitis C Virus Replication with Excellent Pharmacokinetic and Pharmacodynamic Properties [J].
Vernachio, John H. ;
Bleiman, Blair ;
Bryant, K. Dawn ;
Chamberlain, Stanley ;
Hunley, Damound ;
Hutchins, Jeff ;
Ames, Brenda ;
Gorovits, Elena ;
Ganguly, Babita ;
Hall, Andrea ;
Kolykhalov, Alexander ;
Liu, Yule ;
Muhammad, Jerry ;
Raja, Nicholas ;
Walters, C. Robin ;
Wang, Jin ;
Williams, Karen ;
Patti, Joseph M. ;
Henson, Geoffrey ;
Madela, Karolina ;
Aljarah, Mohamed ;
Gilles, Arnaud ;
McGuigan, Christopher .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (05) :1843-1851
[30]   Production of infectious hepatitis C virus in tissue culture from a cloned viral genome [J].
Wakita, T ;
Pietschmann, T ;
Kato, T ;
Date, T ;
Miyamoto, M ;
Zhao, ZJ ;
Murthy, K ;
Habermann, A ;
Kräusslich, HG ;
Mizokami, M ;
Bartenschlager, R ;
Liang, TJ .
NATURE MEDICINE, 2005, 11 (07) :791-796